| Financial Year |
March 31 2023 |
| Monetary Funds |
353,600,067.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
856,571,835.14 |
| Advances to Suppliers |
15,647,479.27 |
| Other Receivables |
9,554,226.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
638,794,412.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,982,413.93 |
| Total Current Assets |
2,106,362,581.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
127,293,865.20 |
| Investment Properties |
-- |
| Fixed Assetes |
2,884,800,388.48 |
| Under-construction Projects |
701,339,899.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
366,214,737.29 |
| R&D expenses |
-- |
| Goodwill |
128,911,104.05 |
| Long-Term Deferred and Prepaid Expenses |
123,930,772.08 |
| Deferred Income Tax Assets |
16,928,121.87 |
| Other Non-Current Assets |
68,469,036.74 |
| Sub-Total of Non-Current Assets |
4,467,343,687.77 |
| Total Assets |
6,573,706,269.26 |
| Short-Term Loans |
479,996,690.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
671,035,619.91 |
| Accounts Payable |
805,571,135.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,433,437.83 |
| Taxes Payable |
5,017,687.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,250,663.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
367,644,369.30 |
| Other Current Liabilities |
327,456.27 |
| Sub-Total of Current Liabilities |
2,373,914,908.41 |
| Long-term Loans |
1,442,100,779.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
43,095,757.87 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,677,700.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,573,344,309.82 |
| Total Liabilities |
3,947,259,218.23 |
| Paid-In Capital(Or Share Stock) |
612,618,620.00 |
| Capital Surplus |
1,667,470,537.24 |
| Surplus Reserve |
56,874,207.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
290,068,242.62 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,626,447,051.03 |
| Owner's Equity（Stockholder's Equity） |
2,626,447,051.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,573,706,269.26 |
